Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Tue, 17th Mar 2020 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES PEARSON TO 'NEUTRAL' ('SELL') - PRICE TARGET 605 (505) PENCE

----------

GOLDMAN RAISES INFORMA TO 'NEUTRAL' ('SELL') - PRICE TARGET 729 (744) PENCE

----------

GOLDMAN CUTS RELX PRICE TARGET TO 2185.0 (2302.8) PENCE - 'BUY'

----------

GOLDMAN CUTS AUTO TRADER PRICE TARGET TO 653 (688) PENCE - 'BUY'

----------

GOLDMAN CUTS ITV PRICE TARGET TO 122 (147) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS WPP PRICE TARGET TO 900 (1045) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERGUSON PRICE TARGET TO 7100 (8100) PENCE - 'OVERWEIGHT'

----------

RBC CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 155 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LLOYDS BANKING PRICE TARGET TO 47 (66) PENCE - 'OUTPERFORM'

----------

RBC CUTS HSBC PRICE TARGET TO 440 (520) PENCE - 'UNDERPERFORM'

----------

RBC CUTS BARCLAYS PRICE TARGET TO 120 (170) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES STANDARD CHARTERED TO 'HOLD' ('REDUCE') - TARGET 480 (590) PENCE

----------

HSBC CUTS WPP PRICE TARGET TO 620 (1030) PENCE - 'HOLD'

----------

JPMORGAN CUTS DIAGEO PRICE TARGET TO 2150 (2800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COCA-COLA HBC PRICE TARGET TO 1980 (3000) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1550) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 8000 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6500 (7700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES UNILEVER TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 3850 (4210) PENCE

----------

JPMORGAN CUTS WHITBREAD PRICE TARGET TO 2990 (3800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS INTERCONTINENTAL HOTELS TARGET TO 4150 (4600) P - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1920 (2040) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES JUST EAT TAKEAWAY.COM TO 'BUY' ('HOLD') - PRICE TARGET 8000 PENCE

----------

FTSE 250

----------

GOLDMAN CUTS ASCENTIAL TO 'BUY' ('CONVICTION BUY') - PRICE TARGET 373 (569) PENCE

----------

KEPLER CHEUVREUX RAISES TATE & LYLE TO 'BUY' ('HOLD') - TARGET 720 PENCE

----------

LIBERUM CUTS BALFOUR BEATTY PRICE TARGET TO 320 (400) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 265 (275) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS HAMMERSON PRICE TARGET TO 200 (300) PENCE - 'BUY'

----------

HSBC CUTS 4IMPRINT GROUP PRICE TARGET TO 2215 (2820) PENCE - 'HOLD'

----------

JPMORGAN CUTS BRITVIC PRICE TARGET TO 875 (1065) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS HUNTING PRICE TARGET TO 160 (398) PENCE - 'SELL'

----------

GOLDMAN CUTS JOHN WOOD PRICE TARGET TO 282 (467) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES PETROFAC TO 'BUY' ('NEUTRAL') - TARGET 316 (433) PENCE

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 730 (790) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 270 (375) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN CUTS DAILY MAIL & GENERAL TRUST PRICE TARGET TO 632 (706) PENCE - 'SELL'

----------

LIBERUM CUTS KIER GROUP PRICE TARGET TO 115 (150) PENCE - 'BUY'

----------

BERENBERG CUTS BREEDON PRICE TARGET TO 105 (110) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.